Last reviewed · How we verify
NCT03567421
Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes
trial in Stone;Renal in 2,348 participants. Completed in 31 August 2019.
31 August 2019
Quick facts
| Lead sponsor | Société Internationale d'Urologie |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,348 |
| Start date | 7 June 2018 |
| Primary completion | 31 August 2019 |
| Estimated completion | 31 August 2019 |
| Sites | 50 locations across South Africa, Greece, Malaysia, Taiwan, Saudi Arabia, Indonesia, South Korea, Iran |
Conditions studied
- Stone;Renal — all drugs for Stone;Renal →
- Stone, Kidney — all drugs for Stone, Kidney →
- Stone Ureter — all drugs for Stone Ureter →
Sponsor
Société Internationale d'Urologie
Who can join
Adults 18 to 99, any sex, with Stone;Renal or Stone, Kidney. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The exit strategy after ureteroscopy for stone treatment remains a topic for discussion. Current EAU guidelines on urolithiasis state that postoperative stenting is indicated in patients at increased risk of postoperative complications. Stenting is not considered necessary in all other cases, and after uncomplicated procedures. Objective: To analyse the postoperative ureteral stenting strategy in clinical practice looking at the indication, type of stents used and the duration of stenting after ureteroscopy for stone treatment. Furthermore, the investigators will examine in what setting the stents are being removed postoperatively. Study design: This study is a prospective, observational, international, multicentre registry study executed by uCARE. Study population: All patients \>18 years with a ureter or renal stone who are planned for ureteroscopic treatment by semi-rigid and/or flexible ureteroscopy are eligible for this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03567421
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stone;Renal
Currently open trials in the same condition.
- NCT07306819 — Comparison Between Two Methods for Renal Stone Treatment Mini Percutaneous Nephrolithotomy and Flexible Ureteroscopy Wit · NA · recruiting
- NCT06809582 — Impact of Surgical Position on Stone-Free Rates in Retrograde Intrarenal Surgery · NA · recruiting
Other Société Internationale d'Urologie trials
Trials by the same sponsor.
- NCT03228485 — Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03567421 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société Internationale d'Urologie
- Last refreshed: 13 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03567421.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing